ArticleMolecular diversity2025
Repurposed drugs as PCSK9-LDLR disruptors for lipid lowering and cardiovascular disease therapeutics.
Shelly Singhal Nee Shelly Aggarwal et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it